Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Arrowpoint Investment Partners (Singapore) Pte. Ltd. (CIK 2032331) reported $112.5M across 76 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: IGV ($18.5M, 16.42%), KWEB ($11.4M, 10.12%), GOOGL ($9.0M, 7.96%), SMH ($8.4M, 7.49%), EWZ ($4.6M, 4.09%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | IGV | ISHARES TR | $18.5M | 16.42% | 230,800 | New |
| 2 | KWEB | KRANESHARES TRUST | $11.4M | 10.12% | 400,400 | Added |
| 3 | GOOGL | ALPHABET INC | $9.0M | 7.96% | 31,127 | Added |
| 4 | SMH | VANECK ETF TRUST | $8.4M | 7.49% | 22,000 | New |
| 5 | EWZ | ISHARES INC | $4.6M | 4.09% | 120,000 | New |
| 6 | ASX | ASE TECHNOLOGY HLDG CO LTD | $3.9M | 3.46% | 179,512 | New |
| 7 | IONS | IONIS PHARMACEUTICALS INC | $2.9M | 2.60% | 38,988 | Added |
| 8 | NBIX | NEUROCRINE BIOSCIENCES INC | $2.8M | 2.52% | 21,556 | Added |
| 9 | AXSM | AXSOME THERAPEUTICS INC. | $2.8M | 2.46% | 16,401 | Added |
| 10 | BMRN | BIOMARIN PHARMACEUTICAL INC | $2.8M | 2.45% | 48,719 | New |
| 11 | ASND | ASCENDIS PHARMA A/S | $2.7M | 2.40% | 11,828 | Added |
| 12 | PTCT | PTC THERAPEUTICS INC | $2.7M | 2.40% | 39,701 | Added |
| 13 | PFE | PFIZER INC | $2.0M | 1.78% | 71,313 | Added |
| 14 | JNJ | JOHNSON & JOHNSON | $1.9M | 1.72% | 7,902 | Trimmed |
| 15 | REGN | REGENERON PHARMACEUTICALS | $1.9M | 1.72% | 2,502 | Added |
| 16 | AMGN | AMGEN INC | $1.7M | 1.54% | 4,934 | Trimmed |
| 17 | GILD | GILEAD SCIENCES INC | $1.7M | 1.48% | 11,961 | Trimmed |
| 18 | VRTX | VERTEX PHARMACEUTICALS INC | $1.5M | 1.35% | 3,412 | Added |
| 19 | MCHPP | MICROCHIP TECHNOLOGY INC. | $1.5M | 1.32% | 1.5M | New |
| 20 | UNH | UNITEDHEALTH GROUP INC | $1.4M | 1.25% | 5,216 | New |
| 21 | PRAX | PRAXIS PRECISION MEDICINES I | $1.2M | 1.10% | 3,855 | Added |
| 22 | INSM | INSMED INC | $1.1M | 1.02% | 7,018 | Trimmed |
| 23 | PTGX | PROTAGONIST THERAPEUTICS INC | $983,804 | 0.87% | 9,334 | New |
| 24 | BLTE | BELITE BIO INC | $957,278 | 0.85% | 6,004 | Added |
| 25 | EWT | ISHARES INC | $886,500 | 0.79% | 12,500 | New |
Source: SEC Form 13F filings · as of 2026-03-31